Guido Bocci Selected Research

Pharmaceutical Preparations

1/2022	A 5-Year Study of Lithium and Valproic Acid Drug Monitoring in Patients with Bipolar Disorders in an Italian Clinical Center.
1/2019	Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: Evaluation of the effects of switched schedules and related pharmacodynamics.
1/2019	Dual Kit/Aur Inhibitors as Chemosensitizing Agents for the Treatment of Melanoma: Design, Synthesis, Docking Studies and Functional Investigation.
6/2018	Melanocortin Receptor-4 and Glioblastoma Cells: Effects of the Selective Antagonist ML00253764 Alone and in Combination with Temozolomide In Vitro and In Vivo.
12/2015	Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer.
1/2015	Methods: for studying pharmacogenetic profiles of combination chemotherapeutic drugs.
9/2013	Population pharmacokinetics of daptomycin in patients affected by severe Gram-positive infections.
5/2012	The possible role of chemotherapy in antiangiogenic drug resistance.
1/2012	Population pharmacokinetic analysis of 5-FU and 5-FDHU in colorectal cancer patients: search for biomarkers associated with gastro-intestinal toxicity.
6/2011	Antiproliferative and proapoptotic activity of CLM3, a novel multiple tyrosine kinase inhibitor, alone and in combination with SN-38 on endothelial and cancer cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guido Bocci Research Topics

Disease

54	Neoplasms (Cancer) 01/2022 - 05/2002
16	Breast Neoplasms (Breast Cancer) 03/2022 - 05/2002
13	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 02/2004
11	Anaplastic Thyroid Carcinoma 02/2020 - 04/2012
10	Thyroid Neoplasms (Thyroid Cancer) 01/2020 - 03/2007
9	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2018
7	Prostatic Neoplasms (Prostate Cancer) 12/2016 - 08/2009
7	Macular Degeneration (Age-Related Maculopathy) 01/2016 - 01/2007
4	Drug-Related Side Effects and Adverse Reactions 01/2022 - 01/2004
4	Carcinoma (Carcinomatosis) 05/2021 - 10/2004
4	Neoplasm Metastasis (Metastasis) 01/2017 - 02/2004
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 10/2011
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 02/2021 - 10/2006
3	Colonic Neoplasms (Colon Cancer) 01/2020 - 08/2017
3	Lymphoma (Lymphomas) 12/2018 - 10/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 09/2012 - 09/2004
3	Endometriosis 12/2010 - 11/2003
2	Seizures (Absence Seizure) 01/2022 - 01/2022
2	Brain Neoplasms (Brain Tumor) 01/2022 - 12/2012
2	Melanoma (Melanoma, Malignant) 01/2019 - 10/2005
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 02/2016
2	Triple Negative Breast Neoplasms 01/2016 - 12/2015
2	medullary Thyroid cancer 11/2014 - 02/2014
2	Hepatocellular Carcinoma (Hepatoma) 01/2014 - 11/2006
2	Infections 09/2013 - 04/2010
2	Pre-Eclampsia (Preeclampsia) 02/2013 - 06/2004
2	Neutropenia 12/2011 - 05/2002
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Lewis Lung Carcinoma 05/2021
1	Glioma (Gliomas) 01/2021

Drug/Important Bio-Agent (IBA)

22	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2022 - 09/2004
18	Pharmaceutical PreparationsIBA 01/2022 - 05/2002
12	Fluorouracil (Carac)FDA LinkGeneric 02/2021 - 06/2005
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 10/2003
10	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 09/2006
10	Tyrosine Kinase InhibitorsIBA 01/2018 - 09/2004
8	Bevacizumab (Avastin)FDA Link 03/2022 - 05/2007
7	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 03/2022 - 09/2004
7	Paclitaxel (Taxol)FDA LinkGeneric 03/2022 - 05/2002
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2004
6	Vinorelbine (Navelbine)FDA LinkGeneric 05/2021 - 02/2016
6	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 10/2005
5	ErbB Receptors (EGF Receptor)IBA 07/2016 - 09/2013
5	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2016 - 09/2004
5	pyrimidineIBA 07/2016 - 02/2011
5	Proteins (Proteins, Gene)FDA Link 02/2014 - 10/2005
4	Thrombospondin 1IBA 03/2022 - 10/2003
4	Interleukin-8 (Interleukin 8)IBA 03/2022 - 12/2014
4	Sunitinib (Sutent)FDA Link 01/2019 - 05/2012
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2018 - 09/2004
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022 - 01/2020
3	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 06/2018
3	Celecoxib (Celebrex)FDA Link 02/2021 - 08/2009
3	LigandsIBA 01/2020 - 06/2004
3	AntibodiesIBA 01/2019 - 11/2005
3	pazopanib FDA Link 01/2019 - 04/2015
3	Topotecan (Hycamtin)FDA LinkGeneric 01/2019 - 04/2015
3	Gemcitabine FDA Link 01/2017 - 09/2004
3	Biological ProductsIBA 11/2005 - 11/2003
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2022 - 01/2022
2	Alkylating AgentsIBA 01/2022 - 10/2005
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 01/2021
2	ProdrugsIBA 01/2022 - 02/2021
2	lenvatinibIBA 01/2020 - 05/2018
2	Hormones (Hormone)IBA 01/2019 - 08/2009
2	Phosphotransferases (Kinase)IBA 01/2019 - 02/2014
2	MelanocortinsIBA 06/2018 - 01/2018
2	CalciumIBA 08/2017 - 01/2006
2	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 10/2005
2	Dexamethasone (Maxidex)FDA LinkGeneric 12/2016 - 08/2009
2	Ranibizumab (Lucentis)FDA Link 01/2016 - 04/2013
2	4- chloro- N- (1,1,3- trioxo- 2,3- dihydrobenzo(d)isothiazol- 4- yl)benzamideIBA 11/2014 - 04/2012
2	AmidesIBA 11/2014 - 04/2012
2	Messenger RNA (mRNA)IBA 09/2013 - 11/2006
2	Daptomycin FDA Link 09/2013 - 04/2010
2	Cyclin D1IBA 09/2012 - 06/2011
2	Monoclonal AntibodiesIBA 05/2012 - 09/2004
2	Endothelial Growth FactorsIBA 02/2011 - 05/2002
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2009 - 09/2006
2	DNA (Deoxyribonucleic Acid)IBA 08/2009 - 10/2005
2	Leucovorin (Folinic Acid)FDA Link 10/2006 - 09/2006
1	LithiumIBA 01/2022
1	Histone Deacetylase InhibitorsIBA 01/2022
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2022
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2022
1	Ifosfamide FDA LinkGeneric 01/2022
1	Busulfan (Busulfex)FDA Link 01/2022
1	Interleukin-2 (IL2)IBA 05/2021
1	Interferon-gamma (Interferon, gamma)IBA 02/2021
1	CytokinesIBA 02/2021

Therapy/Procedure

27	Drug Therapy (Chemotherapy) 01/2022 - 09/2006
19	Therapeutics 01/2022 - 05/2002
3	Radiotherapy 11/2021 - 01/2015
3	Castration 12/2016 - 05/2010
2	Heterologous Transplantation (Xenotransplantation) 08/2014 - 02/2011
2	Breast Implants (Breast Implant) 01/2014 - 10/2011
1	Chemoradiotherapy 01/2022